STAT Plus: Pharmalittle: India to ramp up ingredients production; CIA warns employees about taking hydroxycholoroquine
Rise and shine, everyone, another challenging day is on the way. We can tell because…
Category: Pharma
STAT Plus: Pharmalittle: Gilead Covid-19 drug shows early promise; AstraZeneca halts trial due to ‘overwhelming’ benefit
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
Some drugs being tested as Covid-19 treatments could be very cheap to make
Some existing medicines that may be repurposed to fight Covid-19 could also be manufactured profitably…
.jpg)
A key ingredient that compound pharmacies need for hydroxychloroquine skyrockets in price
As global demand intensifies for an old malaria drug that some believe can combat Covid-19,…
STAT Plus: Pharmalittle: Poison control sees more cases after Trump touts malaria drug; Indian companies to double hydroxychloroquine output
And so, another working week will soon come to a close. Not a moment too…
STAT Plus: Pharmalittle: More clinical trials derailed by Covid-19; Pfizer jumpstarts tests on a drug to fight the pandemic
Rise and shine, everyone, another challenging day is on the way. And while it will…
Pfizer says coronavirus drug could enter testing by fall
Pfizer said Thursday it now intends to start human tests on a potential drug to…
STAT Plus: Opioid-overdose prescriptions may go unfilled due to the cost
Although naloxone is widely regarded as an effective antidote for reversing opioid overdoses, a new…
STAT Plus: Pharmalittle: WIPO holds talks to widen access to Covid-19 medical products; DEA moves to ease Covid-19 drug shortages
Good morning, everyone, and welcome to the middle of the week. Although, it might not…
STAT Plus: Lilly lowers most insulin costs to $35 a month in response to Covid-19
In response to the financial hit many people are taking due to the coronavirus pandemic,…
STAT Plus: Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved
Good morning, everyone, and how are you today? As the saying goes, stay on the…
Former Novartis exec wants to repurpose generic drugs to fight Covid-19
As Covid-19 sweeps the globe, a growing number of efforts are underway to quickly research…
A $30 billion gamble: Pandemic expert calls for making Covid-19 vaccines before we know they work
There’s a one-word exit strategy for the devastating Covid-19 pandemic, which is crippling economies around…
WHO director-general endorses a voluntary intellectual property pool to develop Covid-19 products
Amid the race to find a salve for Covid-19, the World Health Organization director-general has…
.jpg)
STAT Plus: Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Gilead ramps up production of experimental Covid-19 treatment amid criticism over access
In response to intensifying demand, Gilead Sciences has been ramping up production of its experimental remdesivir…
STAT Plus: Pharmalittle: Sanofi poised to supply millions of doses of malaria drug; Roche unit apologizes for ‘Wuhan’ virus label
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Large employers could have saved money if more biosimilars had been prescribed
If some of the largest U.S. employers had used biosimilar versions of a pair of…
STAT Plus: Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works
Rise and shine, everyone, another busy day is on the way. How could it be…
STAT Plus: The FDA warns Pfizer over yet another former Hospira manufacturing plant
Amid ongoing concerns over the pharmaceutical supply chain, the Food and Drug Administration has issued…
STAT Plus: FDA asks manufacturers to recall heartburn drugs over traces of a possible carcinogen
After months of deliberation, the Food and Drug Administration has asked all manufacturers of a…
STAT Plus: Pharmalittle: U.S. asks India to list restrictions on pharma ingredients; Giuliani wants FDA to fast-track a drug for Covid-19
Good morning, everyone, and welcome to the middle of the week. Given that so many…
STAT Plus: Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal
Hello, everyone, and how are you coping this morning? We are doing just fine, thank…
STAT Plus: FDA closes review of Novartis data integrity scandal without punishing the drug maker
An embarrassing scandal that Novartis (NVS) endured over data integrity has quietly come to a…
We shouldn’t rush to use an unproven drug to treat the coronavirus
As the pandemic deepens, physicians face an agonizing decision — to medicate or not to…
STAT Plus: ‘It’s the disparity in who gets affected’: A sickle cell doctor tracks dollars and drug development
Sickle cell disease and cystic fibrosis are both rare, genetic diseases. While there are three…
STAT Plus: Pharmalittle: Drug pricing legislation is on the back burner; FDA issues emergency use for old malaria drugs
Good morning, everyone, and welcome to another working week, although it may not quite seem…
STAT Plus: Pharmalittle: Conservative group pushes for malaria drug approval for Covid-19; OTC drug industry to get an overhaul
And so, another working week will soon come to a close. Not a moment too…
STAT Plus: DEA proposes new rule to approve new suppliers of marijuana for research
After years of inactivity, the Drug Enforcement Administration has finally taken steps toward approving more…
STAT Plus: Pharmalittle: Gilead asks FDA to rescind orphan status for Covid-19 drug; Bristol delays MS drug launch due to coronavirus
Good morning, everyone, and how are you today? We hope you are finding ways to…
STAT Plus: Bristol’s MS drug approval is good news for shareholders but patients will have to wait
A new multiple sclerosis medicine from Bristol Myers Squibb (BMY) was approved Thursday by the…
STAT Plus: The tables are turned: Chinese regulator scolds a U.S. company for drug-manufacturing problems
The shoe is on the other foot, so to speak. For the past few years,…
STAT Plus: Pharmalittle: Scientists say coronavirus is not mutating significantly; WHO is asked to pool Covid-19 patent rights
Hello, everyone, and welcome to the middle of the week. Under the circumstances, this is…
India bans exports of drug touted by Trump as potential Covid-19 treatment
The Indian government has banned exports of hydroxychloroquine, the decades-old malaria drug that was touted…
Hospital orders for old malaria drugs have spiked amid coronavirus pandemic
As speculation mounted in recent weeks that a pair of old malaria drugs could combat…
WHO is asked to create a voluntary intellectual property pool to develop Covid-19 products
Seeking to widen access to medical products for combating Covid-19, the Costa Rican government has…
STAT Plus: Pharmalittle: Pharmacy boards limit prescriptions for drugs touted by Trump; Nearly half of trial sites expect disruptions
Hello, everyone, and how are you this morning? Despite the chaos, we are hanging in…
Ecuador becomes the latest country to eye compulsory licensing for Covid-19 products
As the novel coronavirus continues to spread, Ecuador has become the latest country in which…
STAT Plus: An Indian drug maker is slammed by FDA for tossing ‘cartloads of trash bags’ filled with documents
Amid global anxiety over the novel coronavirus, a newly issued warning letter by the Food…
STAT Plus: AbbVie waives all worldwide restrictions on making generic copies of its Kaletra HIV pill
In an unexpected development, AbbVie (ABBV) is waiving restrictions on licenses held by a nonprofit…
STAT Plus: Pharmalittle: Researchers identify 70 drugs for possibly fighting Covid-19; Gilead pauses access to experimental drug
Good morning, everyone, and how are you today? We hope the weekend break was something…
STAT Plus: Pharmalittle: Trump adviser slams PhRMA pushback against ‘American-made’; drug makers boost production of malaria pill for Covid-19
And so, another working week will soon draw to a close. Not a moment too…
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Two manufacturers of a decades-old malaria drug that some research has suggested may be useful…
STAT Plus: Preventing other Shkreli-like debacles may not save the government much money
After Martin Shkreli took a 5,000% price hike on a decades-old medicine and thwarted rivals,…
STAT Plus: Pharmalittle: WHO to launch expansive coronavirus clinical trial; FDA halts some domestic inspections
Rise and shine, everyone, another intense day is on the way. The world seems to…
Coronavirus will have a ‘big impact’ on one-third of U.S. clinical trial sites, survey finds
Nearly one-third of clinical trial sites expect the novel coronavirus will have a “big or…
STAT Plus: Pharmalittle: Blood samples are lacking for coronavirus treatments; Europe counters Trump offer to vaccine maker
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Pharmalittle: FDA gives states an OK to authorize coronavirus tests; more companies race to combat Covid-19
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Merck drug reduces cough frequency but taste alterations could cloud prospects
An experimental pill from Merck significantly reduced the frequency of chronic coughing compared to a…
STAT Plus: Global spending on drugs may hit $1.1 trillion by 2024, but the rate of growth is forecast to slow
Global spending on prescription medicines is forecast to increase between 2% and 5% annually over…